Disclosed are compounds, compositions and methods for treating viral infections, diseases, syndromes, or disorders that are affected by the modulation of STING. Such compounds are represented by Formula (I) as follows: wherein R1A, R1B, R1c, B1, R2A, and R2B are defined herein.揭示用於治療受到STING調節所影響的病毒感染、疾病、症候群、或病症之化合物、組成物及方法。該等化合物係由以下式(I)表示: 其中R1A、R1B、R1c、B1、R2A、以及R2B係如本文所定義。